Slide 1: Investor presentation
Investor presentation www.materialise.com | NASDAQ & EURONEXT: MTLS Q1 2026
Slide 2: Disclaimers
Disclaimers This presentation has been prepared solely for use at this meeting. By reading or reviewing the presentation slides, you agree to be bound by the following limitations. “Presentation” means this document, any oral presentation, any questions and answer session, and any written or oral ma
Slide 3: Agenda
Agenda Brigitte de Vet-Veithen CEO 01. Introducing 3D printing Koen Berges Koen Berges 02. CFO The story of Materialise CFO 03. Our key financials 04. Investment case 2
Slide 4: What is 3D Printing?
What is 3D Printing? 3D printing, also known as Additive Manufacturing, is a process of creating three- dimensional objects by depositing material layer by layer based on a digital design.
Slide 5: Years of evolution vs decades of innovation
300 years of evolution vs 3 decades of innovation Traditional manufacturing has First machine released in 1988 matured over 300 years Steam engine The 3D Systems SLA-1
Slide 6: The Slow Revolution
The Slow Revolution At Materialise we refer to 3D printing as a “Slow Revolution”. While it has transformative potential across industries by enabling customized and on-demand production, its widespread adoption is gradual.
Slide 7: Why 3D Printing?
Fast & Flexible Decentralized Freedom of design Personalized Why 3D Printing? Sustainable Not only a different way to make things, but a way to "make a difference"
Slide 8: Leveraging 3D printing unique benefits
Leveraging 3D printing unique benefits meaningful applications Healthcare Automotive Aerospace Pre-surgical planning, Empowering iterative Shorter lead times, small medical devices, guides, design, shortening supply series, and unrivaled and implants chain and reducing health- design freedom and-saf
Slide 9: Leveraging 3D printing unique benefits
Leveraging 3D printing unique benefits meaningful applications Architecture, Art & Design Consumer goods Machinery and equipment Freedom of design From proof-of-concept Innovative production with incredible detail prototypes to premium tools, prototypes, and end-use goods 3D-printed spare parts
Slide 10: The story of Materialise
* Lr materialise The story of Materialise
Slide 11: The story of Materialise
Fried Hilde Vancraen Ingelaere The story of Materialise Fried Vancraen and Hilde Ingelaere ignited Materialise's journey with one 3D printer and a vision for a healthier world, propelling it to become Europe's premier 3DP software developer and factory.
Slide 12: Building upon 35+ years of industry experience and over a decade of public market presence
Building upon 35+ years of industry experience and over a decade of public market presence 1990 2014 2024 2025 Successful leadership transition • Shareholder structure Other investors 41,0% 58,1% Vancraen family 0,9% Note: Based on the number of shares as at Mar 31, 2026 and transparency notificatio
Slide 13: Key KPI's
Key KPI’s 268M 2500+ 3 529 EUR annual revenue employees business units patents (2025) 6,000+ 21 1.9M+ 70k+ active users of active in countries parts printed in 2025 patients helped in 2025 Materialise software
Slide 14: Global presence
Global presence USA China Japan Malaysia Colombia India Brazil Australia
Slide 15: Empowering customers success across three specialized business units
Empowering customers success across three specialized business units Materialise Materialise Materialise Medical Software Manufacturing
Slide 16: Materialise Medical
Materialise Medical Personalized Solutions for Healthcare Professionals Surgical Personalized Point-of-care planning instrumentation 3D printing and implants
Slide 17: Personalized Solutions for Healthcare Professionals
Personalized Solutions for Healthcare Professionals Improve surgery outcomes through personalized solutions Upload patient’s scans in a secure cloud-based environment 3D print patient-specific anatomical models, Prepare procedures with precise and advanced 3D instrumentation and implants planning wi
Slide 18: Personalized solutions for targeted market segment
Personalized solutions for targeted market segment CMF New markets/technologies Orthognatic surgery Grow an effective and healthy Reconstruction surgery for oncology innovation pipeline or trauma patients Orthopedics Cardiac & Respiratory Knee surgery Scale through partnerships Hip surgery Shoulder
Slide 19: Mass Personalization leads to better outcomes
Mass Personalization leads to better outcomes 30-45min 0.4mm 1.8x surgery time gain accuracy less revisions Related to orthognatic surgery, published by Heufelder, Jones, Ellis and Guzel
Slide 20: Materialise Medical
Materialise Medical Software and services that revolutionize innovative patient-specific treatment 70,000+ 700,000+ patients helped yearly patient-specific models, guides and implants created to date 6,000,000+ patient scans analyzed with our medical software
Slide 21: Materialise Software
Materialise Software Ecosystem to optimize the AM process Instant ordering Data and build Machine Production an quoting preparation communication planning
Slide 22: Materialise Software
Materialise Software Ecosystem to optimize the AM production process
Slide 23: Materialise Software: Trusted partner for maximizing 3D printing
Materialise Software Trusted partner for maximizing the potential of 3D printing 92% ofAMthesystem largest metal manufacturers 85% ofof all automotive companies the Fortune Global 500 68% ofAMthesystem largest industrial manufacturers 40% ofof the top 20 companies the Fortune Global 500
Slide 24: Materialise Manufacturing
Materialise Manufacturing Prototyping and serial manufacturing projects Materialise 3D printing and casting services offer rapid product development and innovative digital manufacturing, from concept to execution. Online 3D Printing Services On-demand manufacturing services Prototyping services o Ge
Slide 25: Materialise Manufacturing
Materialise Manufacturing Delivering high-volume, high-quality end-part production 200+ 850k+ Series parts manufactured 3D Printers in 2025 650k+ 1.9M+ Flying parts Parts printed in 2025 produced
Slide 26: Our financials
Our financials
Slide 27: Consolidated Revenue and Adj. EBIT(DA)
2021-2025 Consolidated Revenue and Adj. EBIT(DA) Revenue Adj. EBITDA & EBIT 16% 8% 12% 12% 12% +7% 4% 0% 10% 13% 267 268 32 32 256 31 31 232 205 19 12 10 10 11 2021 2022 2023 2024 2025 -3 2021 2022 2023 2024 2025 Adj. EBITDA Adj. EBIT x% % Adj. EBTDA margin [Data in mEUR unless noted otherwise. All
Slide 28: Revenue and Adj. EBITDA by segment
2021-2025 Revenue and Adj. EBITDA by segment Medical Software Manufacturing CAGR 4Y 16% CAGR 4Y -1% CAGR 4Y 1% 15% 15% 19% 16% 7% -3% -13% 16% 134 Revenue 116 101 103 110 107 85 2% 2% -1% -7% 89 92 73 43 44 44 44 41 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 28% 22% 2
Slide 29: Profitable operations supported by a strong balance sheet and healthy cash flow
FY 2025 Profitable operations supported by a strong balance sheet and healthy cash flow generation 268m 134m 16m Revenue Cash reserves Free Cash Flow 2025 2025 2025 11m 63m 16m ADJ EBIT Gross Debt Capex 2025 2025 2025 [Data in mEUR unless noted otherwise. All numbers and percentages rounded]
Slide 30: Investment case
-_. materialise Innovators you ean count on Investment case
Slide 31: What makes Materialise unique?
Collaboration Software Digitization 3D Printing expertise What makes Personalization Materialise unique? Engineering on anatomy Sustainability
Slide 32: At Materialise, we are change agents
Why Materialise? At Materialise, we are change agents We are uniquely positioned to shape what comes next: enabling AM to scale faster than ever while truly making an impact. • by bringing personalized care not to the individual, but to the masses • by extending our knowledge & expertise to certifie
Slide 33: Why Now? We seize the moment
Why Now ? We seize the moment 1. Growth industries set the pace Healthcare remains a key growth engine Accelerating opportunities in Defense and Aerospace markets 2. The mainstreaming of AM creates new opportunities The arrival of affordable and high-quality 3D printers accelerates the move from pro
Slide 34: Why a Dual Listing?
Why a Dual Listing ? A stronger foundation to support our global ambitions • Complemented our >10 years Nasdaq listing with additional Euronext Brussels listing since end 2025, enabling us to deepen our presence in Europe and strengthen our global reach • Expand our investor base, reflecting our com
Slide 35: Thank you
Thank you Contact: Investor Relations Materialise investors@materialise.com